普通人群中抗真菌药物过敏的患病率
该多中心回顾性队列研究纳入2023年五大学术中心共1 704 176例患者,旨在明确加州大学健康系统报告的抗真菌药物过敏患病率及有抗真菌药物给药记录患者中的发生率。结果显示2602例存在抗真菌药物过敏记录,氟康唑患病率最高为0.093%,9829例接受抗真菌药物者中298例报告过敏(2.98%)。结论认为年龄增长和使用抗真菌治疗与抗真菌药物过敏患病率相关。
要点
- 氟康唑过敏患病率最高,为1591例(0.093%)。
- 9829例接受抗真菌药物者中298例报告过敏(2.98%)。
- 年龄增长和使用抗真菌治疗与抗真菌药物过敏患病率相关。
核心结论
- 年龄增长和使用抗真菌治疗与抗真菌药物过敏患病率相关。
- 抗真菌药物过敏率(患病率和发生率)与已报道的抗菌药物过敏率相当,且以氟康唑最高。
研究设计与样本
- 多中心回顾性队列审查,纳入2023年五大学术中心所有患者就诊记录,共1 704 176例患者。
- 主要结局为加州大学健康系统报告的抗真菌药物过敏患病率,次要结局为有抗真菌药物给药记录患者中的抗真菌药物过敏发生率。
主要发现
- 共纳入1 704 176例患者,其中2602例存在抗真菌药物过敏记录。
- 抗真菌药物过敏患病率:氟康唑1591例(0.093%),一般抗真菌药物过敏395例(0.023%),三唑类361例(0.021%),伊曲康唑145例(0.008%),两性霉素110例(0.006%),氟胞嘧啶<10例(0.001%)。
- 次要结局中,9829例患者接受了抗真菌药物,298例报告抗真菌药物过敏(2.98%)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Invasive fungal infections are increasing in frequency and are associated with high patient morbidity and mortality. The use of antifungal therapy is thus also increasing, and patients reporting hypersensitivity or allergic reactions to the limited antifungal agents currently available complicates management. There are no prior studies defining the incidence of antifungal allergies reported by patients. METHODS: A multicentre retrospective cohort review of all patient encounters at five large academic centres during 2023 was conducted. The primary outcome of this study was to find the prevalence of reported antifungal allergy across the University of California Health System, and secondarily determine the incidence of antifungal allergies among patients with documented administration of antifungal agent. RESULTS: A total of 1 704 176 patients were included and 2602 patients exhibited a documented antifungal allergy. Prevalences of antifungal allergies were: fluconazole 1591 (0.093%), general antifungal allergy 395 (0.023%), triazole 361 (0.021%), itraconazole 145 (0.008%), amphotericin 110 (0.006%) and flucytosine <10 (0.001%). In the secondary outcome (incidence), 9829 patients received an antifungal agent and 298 reported an antifungal allergy (2.98%). CONCLUSIONS: Increasing age and use of antifungal therapy are associated with antifungal allergy prevalence. Antifungal allergy rates (prevalence and incidence) are also comparable to the rates reported for antibacterial agents and are highest with fluconazole.
引用
- Shiferaw MW, Donnelley MA, Thompson GR, et al. Prevalence of antifungal allergies in the general population. J Antimicrob Chemother. 2025. PMID: 39960075. doi:10.1093/jac/dkaf037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。